Australia Validated for Trachoma Elimination, Joining 29 Nations

Australia has become the 30th country to receive WHO validation for eliminating trachoma as a public health problem, a designation that carries direct implications for how community-integrated disease management programmes are designed and resourced across high-income nations with persistent endemic pockets in remote populations.

Trachoma, caused by Chlamydia trachomatis and classified by WHO as a neglected tropical disease (NTD), is the world's leading infectious cause of blindness. Repeated infections lead to eyelid scarring, inward-turning eyelashes, and irreversible vision loss if untreated. Australia's elimination was concentrated in remote Aboriginal and Torres Strait Islander communities, where the disease persisted long after it had disappeared from the broader population. The National Trachoma Management Programme, established in 2006, implemented the WHO-recommended SAFE strategy: surgery for trichiasis, antibiotics to treat active infection, facial cleanliness promotion, and environmental improvement.

A notable departure from standard NTD protocol was Australia's use of targeted, community-level treatment data rather than mass drug administration, integrated with environmental health programmes covering housing, water, and sanitation infrastructure. Regular screening by qualified health workers across all at-risk communities formed a core programme component, delivered through coordinated federal, state, Aboriginal community-controlled health services, and local community partnerships.

"Elimination of trachoma is a win for the eye health of communities across Australia, particularly those whose lives have been impacted by a disease that is entirely preventable," said Mark Butler, Australia's Minister for Health and Ageing. Malarndirri McCarthy, Minister for Indigenous Australians, credited Aboriginal Community Controlled Health Organisations and local health workers as central to the outcome. WHO Director-General Dr Tedros Adhanom Ghebreyesus cited the result as evidence of what sustained political commitment and equity-focused partnerships can achieve against NTDs, which collectively affect more than one billion people worldwide.

Source: World Health Organization, 29 April 2026.